Next, the therapeutic potential of the ExSpeU1s was assessed in a transgenic mouse model that carries the ELP1 splicing mutation and has the same tissue-specific mis-splicing observed in FD patients, but which does not exhibit any symptoms. The gene discussed is ELP1; the disease is Fabry disease.